|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Cognition Disorders | |||||
| Mood Disorders | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Disease | |||||
| 3 | More general conditions related to this trial | ||||
| Delirium, Dementia, Amnestic, Cognitive Disorders | |||||
| Mental Disorders | |||||
| Pathologic Processes | |||||
| 4 | Interventions listed in this trial | ||||
| Estrogen | |||||
| Testosterone | |||||
| 5 | More general drug interventions related to this trial | ||||
| Androgens | |||||
| Hormones | |||||
| Hormones, Hormone Substitutes, and Hormone Antagonists | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| 6 | Sponsors listed in this trial | ||||
| National Institute on Aging (NIA) | |||||